Opposition members of the parliamentary caucus on the Trans-Pacific Partnership Agreement (TPPA) have accused International Trade and Investment Minister Mustapa Mohamed of misleading the public on its impact on the cost of medicines.

They said that while Mustapa told the public that Malaysia had only been granted a five-year protection period for clinical trial data, the TPPA actually stipulates two options.